Gene, cell type, and drug prioritization analysis suggest genetic basis for the utility of diuretics in treating Alzheimer disease
Summary: We introduce a user-friendly tool for risk gene, cell type, and drug prioritization for complex traits: GCDPipe. It uses gene-level GWAS-derived data and gene expression data to train a model for the identification of disease risk genes and relevant cell types. Gene prioritization informati...
Main Authors: | Daria Pinakhina, Alexander Loboda, Alexey Sergushichev, Mykyta Artomov |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | HGG Advances |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666247723000350 |
Similar Items
-
Prioritizing Suggestive Candidate Genes in Migraine: An Opinion
by: Simona Denise Frederiksen
Published: (2022-06-01) -
The general prioritization framework
by: Alexey Malishevsky
Published: (2016-08-01) -
GWAS of depression in 4,520 individuals from the Russian population highlights the role of MAGI2 (S-SCAM) in the gut-brain axis
by: Daria Pinakhina, et al.
Published: (2023-01-01) -
System-Level Analysis of Alzheimer’s Disease Prioritizes Candidate Genes for Neurodegeneration
by: Jeffrey L. Brabec, et al.
Published: (2021-04-01) -
Risk Prioritization tools for emerging and epidemic-prone diseases: A One Health scoping review
by: Sandul Yasobant, et al.
Published: (2024-02-01)